MANGALAM DRUGS AND ORGANICS
Back to Balance Sheet
|
MANGALAM DRUGS AND ORGANICS Last 5 Year Total Non-Current Liabilities History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹42 Cr | ₹48 Cr | ₹24 Cr | ₹17 Cr | ₹25 Cr |
What is the latest Total Non-Current Liabilities ratio of MANGALAM DRUGS AND ORGANICS ?
Year | Total Non-Current Liabilities |
---|---|
Mar2023 | ₹42 Cr |
Mar2022 | ₹48 Cr |
Mar2021 | ₹24 Cr |
Mar2020 | ₹17 Cr |
Mar2019 | ₹25 Cr |
How is Total Non-Current Liabilities of MANGALAM DRUGS AND ORGANICS Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹42 Cr | -11.38 | |
Mar2022 | ₹48 Cr | 96.95 | |
Mar2021 | ₹24 Cr | 40.46 | |
Mar2020 | ₹17 Cr | -30.61 | |
Mar2019 | ₹25 Cr | - |
Compare Total Non-Current Liabilities of peers of MANGALAM DRUGS AND ORGANICS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANGALAM DRUGS AND ORGANICS | ₹159.7 Cr | 0.5% | 3.6% | -11.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹361,916.0 Cr | 0.3% | -7.5% | 53.9% | Stock Analytics | |
CIPLA | ₹115,034.0 Cr | 1.1% | -4.8% | 56.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,929.0 Cr | 1.6% | 1.6% | 27.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,873.0 Cr | -1.9% | 10.7% | 21.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,322.0 Cr | 5.2% | -0.2% | 90.1% | Stock Analytics |
MANGALAM DRUGS AND ORGANICS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANGALAM DRUGS AND ORGANICS | 0.5% |
3.6% |
-11.2% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses